NAT10 and breast carcinoma: The correlation analysis between genes of interest in different single-cell datasets and functional status in the CancerSEA: http://biocc.hrbmu.edu.cn/CancerSEA/ showed that NAT10 may be involved in DNA repair in breast cancer, indicating that NAT10 inhibition may enhance the sensitivity to olaparib by regulating DNA damage (Figure 2A).